摘要
为观察痛泻要方治疗肠易激综合征的临床疗效,将108例肠易激综合征患者分为两组,治疗组60例采用口服痛泻要方治疗,对照组48例采用口服谷维素片联合复方地芬诺酯片治疗,对比两组临床疗效。结果显示,治疗组总有效率为88.3%,对照组为66.7%,两组疗效比较有统计学意义(P〈0.05)。结果表明,痛泻要方治疗肠易激综合征疗效确切,无毒副作用。
In order to observe the clinical efficacy of the formula for pain and diarrhea in treating irritable bowel syndrome(IBS), 108 cases were divided into two groups. The formula was given to treatment group ( n =60 ) orally,and oryzanol tablets plus compound diphenoxylate tablets to control group ( n =48) orally. Clinical efficacy was compared and observed in two groups. The results showed that the total effective rate was 88.3% in treatment group and 66.7 G in control group, and significant difference was found between the two groups( P 〈0.05). It is concluded that the formula of pain and diarrhea is effective for IBS and has no toxic side effects.
出处
《中国肛肠病杂志》
2013年第3期48-49,共2页
Chinese Journal of Coloproctology
关键词
肠易激综合征
痛泻要方
疗效观察
Irritable bowel syndrome
The formula for pain and diarrhea
Clinical effect observation